Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials.
about
A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal CancerMultidisciplinary treatment of rectal cancer in 2014: where are we going?Prognosis of rectal cancer patients improves with downstaging by intensified neoadjuvant radiochemotherapy - a matched pair analysis.Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications.A phase I dose escalation study of oxaliplatin plus oral S-1 and pelvic radiation in patients with locally advanced rectal cancer (SHOGUN trial).Detection of morphologic alterations in rectal carcinoma following preoperative radiochemotherapy based on multiphoton microscopy imagingPrognostic value of CD133 expression in cancer patients treated with chemoradiotherapy: a meta-analysis.The prognostic significance of tumor epidermal growth factor receptor (EGFR) expression change after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.The current state of targeted agents in rectal cancer.Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer.A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinomaFactors that affect PERCIST-defined test-retest comparability: an exploration of feasibility in routine clinical practice.Emerging role of intensity-modulated radiation therapy in anorectal cancer.Particle radiation therapy for gastrointestinal malignanciesLong-term oncologic outcomes of neoadjuvant concurrent chemoradiotherapy with capecitabine and radical surgery in locally advanced rectal cancer: 10-year experiences at a single institution.Multidisciplinary treatment of locally advanced rectal cancer: a literature review. Part 1.Cetuximab and chemoradiation for rectal cancer--is the water getting muddy?Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study.Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis.Critical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation.MR imaging for rectal cancer: the role in staging the primary and response to neoadjuvant therapy.Whole-body PET/MRI for colorectal cancer staging: Is it the way forward?Does residual microscopic disease after chemoradiotherapy for locally advanced rectal cancer translate into a good clinical outcome?Local excision for more advanced rectal tumors.Phase II study of pre-operative radiotherapy with capecitabine and oxaliplatin for rectal cancer and carcinoembryonic antigen as a predictor of pathological tumour response.Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy?The value of diffusion kurtosis imaging in assessing pathological complete response to neoadjuvant chemoradiation therapy in rectal cancer: a comparison with conventional diffusion-weighted imaging.Preoperative intensified radiochemotherapy for rectal cancer: experience of a single institution.Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study.Is there a benefit in using magnetic resonance imaging in the prediction of preoperative neoadjuvant therapy response in locally advanced rectal cancer?Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).Pim-3 as a potential predictor of chemoradiotherapy resistance in locally advanced rectal cancer patients.Morphologic predictors of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.Value of percent change in tumoral volume measured at T2 -weighted and diffusion-weighted MRI to identify responders after neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinoma.Trends in intensity modulated radiation therapy use for locally advanced rectal cancer at National Comprehensive Cancer Network centers.Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer.Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy.Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3T MR: initial experience.
P2860
Q26739607-3B1D8152-BFF0-4323-86DF-CFED885A6A62Q34093825-7171FBAD-DAB9-44C0-B295-F529BE404F2CQ34943505-1B55255D-C0A3-4625-A0B7-080C446D42F5Q35001108-2B94BF05-45CB-4EF6-8C81-AA2AA3A70CB5Q35033392-0D566F94-D1E7-427F-9FC3-71EF11E0D2E2Q35215682-C1E6BD65-7C6D-4A90-A07E-E48A9F3EF247Q35305771-4863C324-BD93-43DC-BCB5-A05EA68878C6Q35867312-541A26C5-8532-45FD-A9A3-9D4E9E46B859Q35996651-EC4387D2-E34F-4DC0-B4A1-8148DA1A541AQ36540452-240F1E39-3F20-40AC-8F69-671DB443C92CQ36609922-F4905352-A620-44F9-B0C4-17B71EA2CB36Q36610100-6FE3B998-FF4D-4BCE-8E45-BD685DA79748Q36922653-63DD14DF-789A-4170-901A-09805FEC14B3Q36961779-72399EBE-1AD8-427C-AB5D-531015103D5EQ37134438-D11D8BC5-9C21-4E4C-B3BB-9339A2B951E7Q37153300-5DC2C9B6-1AB0-4032-9759-591679CC0DF6Q37339474-AD01BF53-3A6D-477E-91B5-A25B96EDC4DEQ37565629-FDCE1BEF-96F3-4E4A-BCF3-F59F96D64188Q37697800-6CC06BDF-3799-4AFA-A928-4412EB6C8B22Q37699754-C42E6BA9-0C02-4CB4-9B69-7D48BE81FF5BQ37995506-8A5EF40A-ED55-4B12-951E-A9070684AE43Q38005955-447BCC00-6898-4465-8485-B6A6CBECA8A4Q38222387-A31AB3FA-390E-4BEE-8478-223EB523D185Q38877730-F54A7B61-9A0F-4567-901B-1D01D79E1FF0Q39543151-047CB856-180D-460A-B294-9EB419116941Q40073472-18BA9CB1-68A6-4AA9-87D5-DD885355293AQ43048706-67DBC87C-E814-4A8D-A431-4CEBFA7D56EFQ43431563-81D56774-30F2-4599-A61E-1D96D1043158Q44755792-DA0B4364-3CAB-4023-A1BA-C5B928A568C0Q44801406-4B3158A6-B509-4D65-8C5E-EC9BADDFFC81Q46156144-291E69FE-6C0C-4583-9613-AD7DB68FD954Q46603740-51172EA0-335F-4BBF-96D5-16D1A279DAA4Q46695789-C9AC1260-F4D4-4453-8763-4296FC08A334Q47112282-9356E249-D367-452C-917B-BC3F0CE4481FQ49467615-4E5E9689-79D1-46BB-BE0E-C8E99632C97FQ50894922-172FC46C-CA8E-471C-8DF7-070C2DF489F4Q52647513-7CD35618-3E27-4364-8AED-46DEFF6563B4Q53190349-1987DFEC-787B-4F56-96A2-C2AD24679244Q53324505-BC5DB852-6173-473E-8390-D787C78970D0Q54613465-96AD99B9-9EBA-4C42-A757-8AA5D48199B2
P2860
Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Pathological complete response ...... alysis of phase II/III trials.
@ast
Pathological complete response ...... alysis of phase II/III trials.
@en
type
label
Pathological complete response ...... alysis of phase II/III trials.
@ast
Pathological complete response ...... alysis of phase II/III trials.
@en
prefLabel
Pathological complete response ...... alysis of phase II/III trials.
@ast
Pathological complete response ...... alysis of phase II/III trials.
@en
P2093
P2860
P921
P356
P1476
Pathological complete response ...... nalysis of phase II/III trials
@en
P2093
P2860
P304
P356
10.1259/BJR/86650067
P407
P577
2005-10-01T00:00:00Z